World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
15240
World Ranking
4190
National Ranking
1912

Peter A. Sieling publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter A. Sieling sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 124 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Peter A. Sieling D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter A. Sieling sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Peter A. Sieling is affiliated with the University of California, Los Angeles in the United States. Their research focuses on multiple areas within medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. The scientist's work spans several subfields including infectious diseases, immunology, genetics, molecular biology, and oncology.

The recent publication record of Peter A. Sieling reflects a strong emphasis on SARS-CoV-2 and COVID-19 research as well as immunotherapy and immune responses. Their scholarly output covers virus-based gene therapy and CAR-T cell therapy research, alongside COVID-19 clinical research studies, mitochondrial function and pathology, and the development of vaccines and immunoinformatics approaches.

Key recent papers authored by or co-authored with Peter A. Sieling include:

  • Pressure-Driven Mitochondrial Transfer Pipeline Generates Mammalian Cells of Desired Genetic Combinations and Fates, 2020, Cell Reports
  • Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice, 2021, Scientific Reports
  • A Next Generation Bivalent Human Ad5 COVID-19 Vaccine Delivering Both Spike and Nucleocapsid Antigens Elicits Th1 Dominant CD4+, CD8+ T-cell and Neutralizing Antibody Responses, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge, 2021, Frontiers in Immunology
  • Complete Protection of Nasal and Lung Airways Against SARS-CoV-2 Challenge by Antibody Plus Th1 Dominant N- and S-Specific T-Cell Responses to Subcutaneous Prime and Thermally-Stable Oral Boost Bivalent hAd5 Vaccination in an NHP Study, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors of Peter A. Sieling are:

  • Shahrooz Rabizadeh
  • Kayvan Niazi
  • Adrian Rice
  • Annie Shin
  • Lise Zakin

The most common publication venues for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Regular and Young Investigator Award Abstracts
  • Cell Reports
  • Scientific Reports
  • Frontiers in Immunology

Main fields of study represented in Peter A. Sieling's research contributions are:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology
  • Immunology and Microbiology

Areas of specialized interest based on subfields include:

  • Infectious Diseases
  • Immunology
  • Genetics
  • Molecular Biology
  • Oncology

Principal research topics explored are:

  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • COVID-19 Clinical Research Studies
  • Vaccines and immunoinformatics approaches
  • Mitochondrial Function and Pathology

Best Publications

  • Induction of Direct Antimicrobial Activity Through Mammalian Toll-Like Receptors

    Sybille Thoma-Uszynski;Steffen Stenger;Osamu Takeuchi;Maria Teresa Ochoa

  • CD1-restricted T cell recognition of microbial lipoglycan antigens.

    P. A. Sieling;D. Chatterjee;S. A. Porcelli;T. I. Prigozy

  • Activation of Toll-Like Receptor 2 in Acne Triggers Inflammatory Cytokine Responses

    Jenny Kim;Maria-Teresa Ochoa;Stephan R. Krutzik;Osamu Takeuchi

  • Bacterial Lipopolysaccharide Activates NF-κB through Toll-like Receptor 4 (TLR-4) in Cultured Human Dermal Endothelial Cells DIFFERENTIAL EXPRESSION OF TLR-4 AND TLR-2 IN ENDOTHELIAL CELLS

    Emmanuelle Faure;Ozlem Equils;Peter A. Sieling;Lisa Thomas

  • Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis

    Ulrich E Schaible;Florian Winau;Peter A Sieling;Karsten Fischer

  • Vitamin D Is Required for IFN-γ–Mediated Antimicrobial Activity of Human Macrophages

    Mario Fabri;Steffen Stenger;Dong Min Shin;Jae Min Yuk

  • Microbial Dysbiosis Is Associated with Human Breast Cancer

    Caiyun Xuan;Jaime M. Shamonki;Alice Chung;Maggie L. DiNome

  • TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells

    Stephan R Krutzik;Belinda Tan;Huiying Li;Maria Teresa Ochoa

  • Ito cells are liver-resident antigen-presenting cells for activating T cell responses.

    Florian Winau;Guido Hegasy;Ralf Weiskirchen;Stephan Weber

  • Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells.

    D. Branch Moody;Bruce B. Reinhold;Mark R. Guy;Evan M. Beckman

  • A Role for Triggering Receptor Expressed on Myeloid Cells-1 in Host Defense During the Early-Induced and Adaptive Phases of the Immune Response

    Joshua R. Bleharski;Viviane Kiessler;Cecilia Buonsanti;Peter A. Sieling

  • Activation and regulation of Toll-like receptors 2 and 1 in human leprosy.

    Stephan R. Krutzik;Maria Teresa Ochoa;Peter A. Sieling;Satoshi Uematsu

  • The Mannose Receptor Delivers Lipoglycan Antigens to Endosomes for Presentation to T Cells by CD1b Molecules

    Theodore I Prigozy;Peter A Sieling;Daniel Clemens;Phoebe L Stewart

  • Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells

    Robert E. Hunger;Peter A. Sieling;Maria Teresa Ochoa;Makoto Sugaya

  • Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.

    P A Sieling;J S Abrams;M Yamamura;P Salgame

  • CD1-Restricted Microbial Lipid Antigen-Specific Recognition Found in the CD8+ αβ T Cell Pool

    Jean Pierre Rosat;Ethan P. Grant;Evan M. Beckman;Christopher C. Dascher

  • CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family.

    Evan M. Beckman;Agustín Melián;Samuel M. Behar;Peter A. Sieling

  • T-cell release of granulysin contributes to host defense in leprosy.

    Maria Teresa Ochoa;Steffen Stenger;Peter A. Sieling;Sybille Thoma-Uszynski

  • Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy

    Rosane B. Oliveira;Maria T. Ochoa;Peter A. Sieling;Thomas H. Rea

  • TGF-α Regulates TLR Expression and Function on Epidermal Keratinocytes

    Lloyd S. Miller;Ole E. Sørensen;Philip T. Liu;H. Ray Jalian

Frequent Co-Authors

Robert L. Modlin
Robert L. Modlin University of California, Los Angeles
Thomas H. Rea
Thomas H. Rea University of Southern California
Steven A. Porcelli
Steven A. Porcelli Albert Einstein College of Medicine
Barry R. Bloom
Barry R. Bloom Harvard University
Steffen Stenger
Steffen Stenger University of Ulm
Patrick J. Brennan
Patrick J. Brennan Colorado State University
Stefan H. E. Kaufmann
Stefan H. E. Kaufmann Max Planck Institute for Infection Biology
John T. Belisle
John T. Belisle Colorado State University
Ulrich E. Schaible
Ulrich E. Schaible Research Center Borstel - Leibniz-Center for Medicine and Biosciences
Euzenir Nunes Sarno
Euzenir Nunes Sarno Oswaldo Cruz Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, combining this field with nursing can open diverse career pathways. Many students explore advanced practice roles, such as Acute Care Nurse Practitioner programs, which focus on specialized patient care in critical settings. To understand the transition into these roles, reviewing acnp programs is a great starting point.

Several accelerated options are available for aspiring nurse practitioners. These programs enable students to achieve nurse practitioner qualifications efficiently, often through flexible online formats. Exploring the best accelerated np programs can guide candidates toward quality education that fits their schedule and career goals.

For those without prior nursing experience, starting with online nursing degrees tailored for non-nurses is an effective pathway. In particular, individuals in Florida can benefit from reviewing online rn programs for non nurses in florida to begin their nursing careers and eventually specialize in immunology-related fields.

Lastly, if seeking a faster route into nursing, research into accelerated nursing programs offers valuable options. These programs provide solid clinical training while reducing the time spent completing foundational nursing education, which is beneficial for a timely pivot towards immunology specializations.

Best Scientists Citing Peter A. Sieling

Trending Scientists

Recently Published Articles